Article
Differentiation therapy: Unlocking phenotypic plasticity of hepatocellular carcinoma
17 Oct 2022
Abstract excerpt
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors. The current treatment of HCC mainly includes surgery, chemotherapy, and liver transplantation. HCC differentiation therapy aims to restore tumor cells' normal liver characteristics and unlock their phenotypic plasticity. Understanding the molecular and signaling pathways that control HCC differentiation can help identify new targets for...
Topics
Join the communities discussing this publication.
